Client Successes

Trinity Medical Corporation

Without NMSBA’s assistance, I would be spinning my wheels. Sandia’s Bob Winters was the right person at the right time.

airems.jpg

Daniel Barela, the founder of Trinity Medical Corporation, currently serves as an Emergency Medical Services (EMS) Flight Paramedic. Barela noticed that often there are not enough hands available to apply pressure on the esophagus to prevent passive regurgitation and pulmonary aspiration while performing CPR. Barela scoured medical literature and clinical studies to determine the most effective amount of pressure and application method. Barela’s research resulted in an invention that can be applied to the throat as an alternative to hand pressure.

Once Barela designed a prototype for the medical device, he sought a way to construct the device to apply specific and accurate pressures: too little and the device would not prevent aspiration, too much and the device could block airflow. To help Barela with material choices and mechanical design, the NMSBA Program looked to SNL’s Organic Materials Department in Advanced Manufacturing for assistance.

Barela showed the device to Bob Winters, a specialist in innovative prototype fabrication, materials technology, and engineering design. Winters helped Barela develop a “water faucet” feature that incorporates spring action precision to maintain appropriate pressure with components to “lock-out” further adjustment. Without NMSBA’s assistance, Barela says, “I would be spinning my wheels. Bob Winters was the right person at the right time.” Having met this technical milestone in the development of his invention, Barela currently seeks a second patent for his revised prototype.

Winters optimization of the new prototype into an injection-moldable design will allow the medical device to be mass-produced. As a result, Trinity Medical is seeking clinical trials at UNM and is in position to pursue additional investment capital through Technology Ventures Corporation (TVC). Once Trinity Medical wins FDA approval for the medical device, the company can move into production with plans to manufacture two million units a year in Albuquerque.